Aberle Stephan W, Puchhammer-Stöckl Elisabeth
Institute of Virology, University of Vienna, Austria, Kinderspitalgasse 15, A-1095 Vienna, Austria.
J Clin Virol. 2002 Jul;25 Suppl 1:S79-85. doi: 10.1016/s1386-6532(02)00037-9.
Human herpesviruses may cause infections of the central nervous system (CNS). The early diagnosis of herpesvirus-associated neurological diseases is of high importance.
The objective of this paper is to summarize the experience gained with the diagnosis of herpesvirus infections of the CNS at our institute by polymerase chain reaction (PCR)-based assays within the past few years.
A retrospective analysis of herpesvirus desoxy ribonucleic acid (DNA)-positive cerebrospinal fluid (CSF) samples was performed, with particular emphasis on data obtained by quantification of virus DNA in CSF by newly established real-time quantitative PCR assays.
Herpesviruses were found in 26.6% of all virus-positive CSF samples detected at our institute between 1995 and 2001. The overall broad testing for different herpesviruses from CSF has led to an increase in the detection rate, especially in relation to varicella zoster virus (VZV)-associated CNS disease. The herpesvirus DNA load in CSF was investigated by TaqMan real-time PCR assays that were established for the individual herpesviruses. The amount of virus varied among the individual diseases, associated with herpes simplex virus type 1, herpes simplex virus type 2, VZV and cytomegalovirus, while for Epstein-Barr virus and human herpesvirus type 6 only low levels of virus were detectable in CSF.
A generally broad testing for different herpesviruses in CSF samples is highly recommended. In addition, determination of the virus DNA level in CSF by quantitative assays seems to be of high importance for elucidating aspects concerning the prognosis of disease, the prediction of distinct CNS manifestations, and possibly the differentiation between specific virus-associated disease and unspecific presence of virus in CSF, especially in immunocompromised patients.
人类疱疹病毒可引起中枢神经系统(CNS)感染。疱疹病毒相关神经系统疾病的早期诊断至关重要。
本文的目的是总结过去几年我们研究所通过基于聚合酶链反应(PCR)的检测方法诊断中枢神经系统疱疹病毒感染所获得的经验。
对疱疹病毒脱氧核糖核酸(DNA)阳性的脑脊液(CSF)样本进行回顾性分析,特别强调通过新建立的实时定量PCR检测方法对脑脊液中病毒DNA进行定量所获得的数据。
在1995年至2001年期间,我们研究所检测到的所有病毒阳性脑脊液样本中,26.6%发现有疱疹病毒。对脑脊液中不同疱疹病毒进行全面检测,提高了检出率,尤其是水痘带状疱疹病毒(VZV)相关中枢神经系统疾病。通过为各疱疹病毒建立的TaqMan实时PCR检测方法研究了脑脊液中的疱疹病毒DNA载量。不同疾病中病毒量各不相同,与1型单纯疱疹病毒、2型单纯疱疹病毒、VZV和巨细胞病毒有关,而对于EB病毒和6型人类疱疹病毒,在脑脊液中仅可检测到低水平病毒。
强烈建议对脑脊液样本中的不同疱疹病毒进行全面检测。此外,通过定量检测确定脑脊液中的病毒DNA水平,对于阐明疾病预后、预测特定中枢神经系统表现以及可能区分脑脊液中特定病毒相关疾病和病毒的非特异性存在等方面似乎至关重要,尤其是在免疫功能低下的患者中。